Do anti-amyloid therapies demonstrate clinically meaningful benefit? A Bayesian reappraisal.

Costa T, Sensi SL, Høilund-Carlsen PF, Robakis NK, Vissel B, Espay AJ.

DOI: 10.1177/13872877261469870
Published: 2026-07-23
Container: J Alzheimers Dis
Publisher: Not recorded
Open access: no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1177/13872877261469870,
  title = {Do anti-amyloid therapies demonstrate clinically meaningful benefit? A Bayesian reappraisal.},
  author = {Costa T and  Sensi SL and  Høilund-Carlsen PF and  Robakis NK and  Vissel B and  Espay AJ.},
  year = {2026},
  journal = {J Alzheimers Dis},
  doi = {10.1177/13872877261469870},
  url = {https://doi.org/10.1177/13872877261469870}
}

RIS

TY  - JOUR
TI  - Do anti-amyloid therapies demonstrate clinically meaningful benefit? A Bayesian reappraisal.
AU  - Costa T
AU  -  Sensi SL
AU  -  Høilund-Carlsen PF
AU  -  Robakis NK
AU  -  Vissel B
AU  -  Espay AJ.
PY  - 2026
JO  - J Alzheimers Dis
DO  - 10.1177/13872877261469870
UR  - https://doi.org/10.1177/13872877261469870
ER  -

APA

T, C., SL, S., PF, H., NK, R., B, V., & AJ., E. (2026). Do anti-amyloid therapies demonstrate clinically meaningful benefit? A Bayesian reappraisal.. J Alzheimers Dis. https://doi.org/10.1177/13872877261469870

Source records

europe-pmc · retrieved 2026-09-26T09:41:48.009Z